Literature DB >> 15532836

Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?

Johannes Schmidt1, Stefan Fraunhofer, Markus Fleisch, Hubert Zirngibl.   

Abstract

BACKGROUND/AIMS: Demonstration of unresectability often requires diagnostic laparotomy with high co-morbidity in pancreatic carcinoma. The value of detected peritoneal tumor cells and influence on outcome should be determined.
METHODOLOGY: In a prospective study 150 consecutive patients with pancreatic carcinoma were evaluated. Improvement of diagnostic accuracy in diagnosing unresectability was calculated for combination of CT, endoscopic ultrasonography and peritoneal cytology.
RESULTS: Unexpected subglissonian metastases were found in 10%. 87 patients with peritoneal washings were included in the study, 20 patients with detected peritoneal tumor cells (n=22) were inoperable. In all patients of this group the ventral integrity of pancreas was damaged. In 23 patients with preoperative existent ascites, only in 4 cases could peritoneal tumor cells be detected. In patients with positive cytology together with disrupted ventral pancreatic margin as predictors of unresectability, sensitivity was 100% and specificity 96%.
CONCLUSIONS: Addition of diagnostic laparoscopy combined with peritoneal cytology and minimally invasive palliation procedures (endoscopic biliary prosthesis, laparoscopic gastrojejunostomy) to the staging-protocol for pancreatic carcinoma may decrease operative lethality and unnecessary laparotomies may be avoided safely. As unexpected subglissonian micrometastases may additionally be present in 5-10%, perioperative laparoscopy is always advisable.

Entities:  

Mesh:

Year:  2004        PMID: 15532836

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

Review 2.  [Staging laparoscopy in oncology].

Authors:  H Feussner; F Härtl
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

3.  Endoscopic ultrasound and paracentesis in the evaluation of small volume ascites in patients with intra-abdominal malignancies.

Authors:  Marissa M Montgomery; I Michael Leitman
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Borderline resectable pancreatic cancer.

Authors:  Gauri R Varadhachary; Eric P Tamm; Christopher Crane; Douglas B Evans; Robert A Wolff
Journal:  Curr Treat Options Gastroenterol       Date:  2005-10

Review 5.  The role of staging laparoscopy for intraabdominal cancers: an evidence-based review.

Authors:  L Chang; D Stefanidis; W S Richardson; D B Earle; R D Fanelli
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

6.  Prognostic significance of new onset ascites in patients with pancreatic cancer.

Authors:  Emmanuel E Zervos; Dana Osborne; Brian A Boe; German Luzardo; Steven B Goldin; Alexander S Rosemurgy
Journal:  World J Surg Oncol       Date:  2006-03-28       Impact factor: 2.754

7.  The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging.

Authors:  Mirko D'Onofrio; Valentina Ciaravino; Nicolò Cardobi; Riccardo De Robertis; Paolo Tinazzi Martini; Roberto Girelli; Emilio Barbi; Salvatore Paiella; Enrico Marrano; Roberto Salvia; Giovanni Butturini; Paolo Pederzoli; Claudio Bassi
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.